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Drug Abuse Urine Tests: False-positive Results
Lead author: Joseph A. Woelfel, Ph.D., FASCP, R.Ph., Assistant Editor
Health care professionals are frequently asked questions about false-positive drug testing results. Testing is a common practice in work settings,
rehabilitation programs, the military, and legal and judicial venues. Home testing is popular with the availability of test kits to alleviate parental or
job-seeker concerns. Federally regulated workplace drug testing and most private sector workplace programs specify urine testing as their initial
standard test. Other expanded tests may be required in some settings. Confirmatory tests are sometimes performed using urine or other specimen
sources such as blood, saliva, or hair and usually involve chromatography and mass spectrometry. The federal standard urine test checks for five
categories of drugs: amphetamines, cannabinoids, cocaine, opiates, and phencyclidine. These urine screening tests use immunoassay techniques that
are reliable, easy-to-use, and relatively inexpensive. The immunoassays contain drug-specific antibodies which bind with subject drugs in the urine.
They eliminate the majority of false-negative results but may be associated with some false-positives due to crossreactivity with chemically similar
drugs. Knowing which substances cross-react and at what levels is often helpful in alleviating concerns and identifying follow-up testing.
(See detail document 190212 (The Tricks and Traps of Drug Testing) for information on circumventing drug tests).

Federal Standard Urine Immunoassay Drug Abuse Screening Tests
Substance Abuse
Category

Urine Detection Cut-off
Level (ng/mL)1

Amphetamines

1000

Detection Period after
Last Dose (approximate
days)2,3
2 – amphetamine
3 to 4 - methamphetamine

Examples of Substances
Associated with Falsepositive Results4-7,9
amantadine
amphetamine
benzphetamine
bupropion
chlorbenzorex (Mexico)
chlorpromazine
desipramine
dextroamphetamine
ephedrine
fenproferex (Mexico)
labetalol
methamphetamine

Comments

No studies have shown
false-positive tests
associated with passive
inhalation of
methamphetamine.10

More. . .
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Substance Abuse
Category

Urine Detection Cut-off
Level (ng/mL)1

Detection Period after
Last Dose (approximate
days)2,3

Cannabinoids

50

2 to 8 – single use11
20 to 30 – chronic use

Cocaine

300

2 to 3 – single use
4 to 8 – chronic use

Opiates

2000

1 to 2 – opium
1 to 4 – heroin
3 to 4 – morphine
1 - meperidine

®

Examples of Substances
Associated with Falsepositive Results4-7,9
methylenedioxymethylamphetamine
(MDMA, Ecstasy)
pemoline
pseudoephedrine
phenylephrine
ritodrine
selegiline
trazodone
trimethobenzamide
dronabinol
efavirenz
hemp-containing foods:
Seedy Sweeties,
Cranberry Coconut
Hemp Bar
ibuprofen
ketoprofen
naproxen
piroxicam
proton pump inhibitors
tolmetin
coca leaf teas
topical anesthetics
containing cocaine
dextromethorphan
heroin
poppy seeds and oil
opioid prescription
medications:
codeine
hydromorphone

Comments

Studies have demonstrated
that levels of passivelyinhaled marijuana are
insufficient to test positive
with the screening cut-off
of 50 ng/mL.10

Positive urine drug screens
are highly unlikely for
passively-inhaled cocaine
due to the cut-off.10
In 2000 detection cut-off
limits were raised from 300
ng/mL to 2000 ng/mL to
reduce the frequency of
false-positive results from
poppy seed exposure.7
Ingestion of poppy seed

More. . .
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Substance Abuse
Category

Urine Detection Cut-off
Level (ng/mL)1

Phencyclidine (PCP)

25

Detection Period after
Last Dose (approximate
days)2,3

3 to 7 – single use
14 to 30 – chronic use

Examples of Substances
Associated with Falsepositive Results4-7,9
hydrocodone
morphine
quinine
quinolone antibiotics
rifampin
chlorpromazine
dextromethorphan
diphenhydramine
ketamine
methadone13
thioridazine

Comments

streusel or Danish pastry
can produce urinary levels
above this threshold.12

Detection periods increase
with increasing body fat4

Several home-drug test kits are available on the internet, in pharmacies, or directly from the manufacturer. Some products that have been specifically
approved by the FDA as over-the-counter in vitro diagnostic devices are listed here. These kits use urine immunoassay techniques. Most provide the
shipping materials needed for mailing confirmatory specimens if a positive test result occurs. Other tests using urine, sputum, or hair specimens are
available through internet sources but may not be FDA approved.
FDA-Cleared OTC Home Urine Drug Abuse Tests8
(This chart represents some of the available test kits).
Product Name
“QuickScreen” At Home
Drug Test

®

Availability/Information*
Phamatech, Inc.
10151 Barnes Canyon Rd.
San Diego, CA 92121
888-635-5840
http://www.phamatech.com

Cost**
$29.95 plus shipping and
handling

Time to Results
10 minutes

Comments
The At Home Drug Test
detects amphetamine,
methamphetamine, opiates,
marijuana and cocaine.
The kit includes collection
container, instructions, a
handbook with frequently
asked questions and
materials needed to ship the
sample to the laboratory if
the screening device
indicates the presence of
drugs.
More. . .
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Product Name
Peace of Mind 5 Panel
Home Drug Test

Availability/Information*
Advanced Diagnostics
Laboratories
850 E Franklin Rd. Ste. 407
Meridian, ID 83642-8916
http://www.adldrugtest.com

Cost**
$31.00 plus shipping and
handling

Time to Results
3 minutes

Accu-Stat Drugs of Abuse
Home Test Cup

Accu-Stat Diagnostics
11 Orchard Road Suite 108
Lake Forest, CA 92630
949-916-7560
http://www.accu-stat.com

$27.99 plus shipping and
handling

4 minutes

ADC Advantage Marijuana
and Cocaine Home Test

Inverness Medical
Innovations – Advantage
Diagnostics (ADC)
764 San Aleso Ave
Sunnyvale, CA 94085
800.784.4414

$18.50, includes shipping

Less than 10 minutes

Comments
Tests for amphetamine,
methamphetamine, opiates,
marijuana, phencyclidine,
and cocaine. Laboratory
confirmation included at no
extra charge.
Test for the use of
marijuana, cocaine, opiates,
methamphetamine and
phencyclidine. The kit
includes collection
container, instructions, a
handbook with frequently
asked questions and
materials needed to ship the
sample to the laboratory if
the screening device
indicates the presence of
drugs in the sample.
Tests for marijuana and
cocaine. The kit includes
collection container,
instructions, a handbook
with frequently asked
questions and materials
needed to ship the sample
to the laboratory if the
screening device indicates
the presence of drugs in the
sample. Currently their 5
drug test kits are not
available to consumers.

* Available at select retail stores or internet suppliers, unless otherwise noted.
** Cost information is approximate as of the time this chart was prepared. It is the manufacturer internet price listed as of January 10, 2005.
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Users of this document are cautioned to use their own
professional judgment and consult any other necessary
or appropriate sources prior to making clinical
judgments based on the content of this document. Our
editors have researched the information with input from
experts,
government
agencies,
and
national
organizations. Information and Internet links in this
article were current as of the date of publication.
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